Literature DB >> 33640497

Gestational and peripubertal phthalate exposure in relation to attention performance in childhood and adolescence.

Deborah J Watkins1, John D Meeker2, Marcela Tamayo-Ortiz3, Brisa N Sánchez4, Lourdes Schnaas5, Karen E Peterson6, Martha María Téllez-Rojo7.   

Abstract

The prevalence of Attention Deficit/Hyperactivity Disorder (ADHD) has been increasing. Research suggests that exposure to endocrine disrupting chemicals such as phthalates may play a role, but studies of in utero phthalate exposure and ADHD-related symptoms beyond early childhood are limited. We investigated associations between measures of in utero phthalate exposure and ADHD symptoms, such as inattention and impulsivity, in childhood (age 6-11 years, n = 221) and in adolescence (age 9-18 years, n = 200), as well as cross-sectional relationships between phthalate exposure and ADHD symptoms in adolescence (n = 491) among participants in the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) cohort. Women provided urine samples up to three times during pregnancy and adolescents provided a urine sample at 9-18 years of age for phthalate metabolite measurement. We administered the Conners' Continuous Performance Test (CPT) when children were age 6-11 years and again at 9-18 years of age. We used multivariable linear regression to examine associations between the geometric mean of phthalate metabolite levels across pregnancy and CPT scores in childhood or adolescence separately, adjusting for age, years schooling (at 9-18 only), maternal education, and specific gravity. Although average in utero phthalate concentrations were not associated with CPT scores in childhood, interquartile range (IQR) increases of in utero MBzP, MCPP, and MBP were associated with 4.2%, 4.7%, and 4.5% (p < 0.05) higher Omissions scores in adolescence, respectively, indicating higher inattention. In utero MiBP levels were also associated with higher Inter-Stimulus Interval (ISI) and Variability scores (5.4% and 5.5% per IQR, p < 0.05) in adolescence. In addition, urinary DEHP metabolite levels during adolescence were cross-sectionally associated with poorer scores on several CPT indices indicating greater inattention. These findings suggest that in utero phthalate exposure may have adverse effects on attention, but these effects may not appear until adolescence, a period of extensive neurodevelopment. Future research investigating the long-term effects of in utero phthalate exposure on attention and ADHD in adolescence, as well as identification of potential mechanisms involved, is needed.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; Adolescence; Attention; Gestational exposure; Phthalates

Mesh:

Substances:

Year:  2021        PMID: 33640497      PMCID: PMC8119354          DOI: 10.1016/j.envres.2021.110911

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  57 in total

Review 1.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

2.  Exposure to di-(2-ethylhexyl) phthalate transgenerationally alters anxiety-like behavior and amygdala gene expression in adult male and female mice.

Authors:  Katherine M Hatcher; Jari Willing; Catheryne Chiang; Saniya Rattan; Jodi A Flaws; Megan M Mahoney
Journal:  Physiol Behav       Date:  2019-04-22

3.  Association between phthalates and externalizing behaviors and cortical thickness in children with attention deficit hyperactivity disorder.

Authors:  S Park; J-M Lee; J-W Kim; J H Cheong; H J Yun; Y-C Hong; Y Kim; D H Han; H J Yoo; M-S Shin; S-C Cho; B-N Kim
Journal:  Psychol Med       Date:  2014-11-12       Impact factor: 7.723

4.  Longitudinal assessment of prenatal phthalate exposure on serum and cord thyroid hormones homeostasis during pregnancy - Tainan birth cohort study (TBCS).

Authors:  Han-Bin Huang; Pao-Lin Kuo; Jung-Wei Chang; Jouni J K Jaakkola; Kai-Wei Liao; Po-Chin Huang
Journal:  Sci Total Environ       Date:  2017-11-29       Impact factor: 7.963

Review 5.  The neurodevelopmental role of dopaminergic signaling in neurological disorders.

Authors:  Yunyun Cai; Lingyan Xing; Tuo Yang; Rui Chai; Jiaqi Wang; Jingyin Bao; Weixing Shen; Sujun Ding; Gang Chen
Journal:  Neurosci Lett       Date:  2020-12-02       Impact factor: 3.046

6.  In utero and peripubertal exposure to phthalates and BPA in relation to female sexual maturation.

Authors:  Deborah J Watkins; Martha Maria Téllez-Rojo; Kelly K Ferguson; Joyce M Lee; Maritsa Solano-Gonzalez; Clara Blank-Goldenberg; Karen E Peterson; John D Meeker
Journal:  Environ Res       Date:  2014-08-29       Impact factor: 6.498

7.  Maternal urinary phthalate metabolites during pregnancy and thyroid hormone concentrations in maternal and cord sera: The HOME Study.

Authors:  Megan E Romano; Melissa N Eliot; R Thomas Zoeller; Andrew N Hoofnagle; Antonia M Calafat; Margaret R Karagas; Kimberly Yolton; Aimin Chen; Bruce P Lanphear; Joseph M Braun
Journal:  Int J Hyg Environ Health       Date:  2018-03-23       Impact factor: 5.840

8.  The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review.

Authors:  Ortal Slobodin
Journal:  Eur Addict Res       Date:  2020-06-12       Impact factor: 3.015

9.  Associations between Repeated Measures of Maternal Urinary Phthalate Metabolites and Thyroid Hormone Parameters during Pregnancy.

Authors:  Lauren E Johns; Kelly K Ferguson; Thomas F McElrath; Bhramar Mukherjee; John D Meeker
Journal:  Environ Health Perspect       Date:  2016-05-06       Impact factor: 9.031

Review 10.  The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD.

Authors:  Carlo Agostoni; Maria Nobile; Valentina Ciappolino; Giuseppe Delvecchio; Alessandra Tesei; Stefano Turolo; Alessandro Crippa; Alessandra Mazzocchi; Carlo A Altamura; Paolo Brambilla
Journal:  Int J Mol Sci       Date:  2017-12-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.